Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Berek

Showing results (131-140 of 172) with videos related to

Pageof 18
Sort By:
Obstetrics and Gynecology|June 1, 1982
Carcinoma of the cervix associated with pregnancyN F Hacker, J S Berek, L D Lagasse, et al.
Obstetrics and Gynecology|January 1, 1985
Whole abdominal radiation as salvage therapy for epithelial ovarian cancerN F Hacker, J S Berek, C M Burnison, et al.
Obstetrics and Gynecology|June 1, 1986
Cytoreductive surgery in ovarian carcinoma: feasibility and morbidityA P Heintz, N F Hacker, J S Berek, et al.
Gynecologic Oncology|July 1, 1999
Intraperitoneal alpha-interferon alternating with cisplatin in residual ovarian carcinoma: a phase II Gynecologic Oncology Group studyJ S Berek, M Markman, J A Blessing, et al.
Gynecologic Oncology|January 15, 1999
A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma: a Gynecologic Oncology Group studyL G Feun, J A Blessing, F J Major, et al.
Cytokine|September 1, 1992
Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancersW H Gotlieb, J S Abrams, J M Watson, et al.
Gynecologic Oncology|February 1, 1983
Estrogen and progesterone receptor sites in malignancies of the uterine cervix, vagina, and vulvaL C Ford, J S Berek, L D Lagasse, et al.
Obstetrics and Gynecology|January 1, 1985
Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastasis and survivalJ S Berek, N F Hacker, Y S Fu, et al.
American Journal of Obstetrics and Gynecology|April 1, 1996
Evidence for a unifocal origin in familial ovarian cancerH H Gallion, A Guarino, P D DePriest, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 27, 2003
The use of continuous infusion topotecan in persistent and recurrent ovarian cancerJ C Elkas, C H Holschneider, B Katz, et al.
Pageof 18

Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
Obstetrics and Gynecology|June 1, 1982
Carcinoma of the cervix associated with pregnancyN F Hacker, J S Berek, L D Lagasse, et al.
Obstetrics and Gynecology|January 1, 1985
Whole abdominal radiation as salvage therapy for epithelial ovarian cancerN F Hacker, J S Berek, C M Burnison, et al.
Obstetrics and Gynecology|June 1, 1986
Cytoreductive surgery in ovarian carcinoma: feasibility and morbidityA P Heintz, N F Hacker, J S Berek, et al.
Gynecologic Oncology|July 1, 1999
Intraperitoneal alpha-interferon alternating with cisplatin in residual ovarian carcinoma: a phase II Gynecologic Oncology Group studyJ S Berek, M Markman, J A Blessing, et al.
Gynecologic Oncology|January 15, 1999
A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma: a Gynecologic Oncology Group studyL G Feun, J A Blessing, F J Major, et al.
Cytokine|September 1, 1992
Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancersW H Gotlieb, J S Abrams, J M Watson, et al.
Gynecologic Oncology|February 1, 1983
Estrogen and progesterone receptor sites in malignancies of the uterine cervix, vagina, and vulvaL C Ford, J S Berek, L D Lagasse, et al.
Obstetrics and Gynecology|January 1, 1985
Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastasis and survivalJ S Berek, N F Hacker, Y S Fu, et al.
American Journal of Obstetrics and Gynecology|April 1, 1996
Evidence for a unifocal origin in familial ovarian cancerH H Gallion, A Guarino, P D DePriest, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 27, 2003
The use of continuous infusion topotecan in persistent and recurrent ovarian cancerJ C Elkas, C H Holschneider, B Katz, et al.
Pageof 18